Author

Spyridon Siakavellas

PATIENT PERCEPTIONS ABOUT CAUSES OF FLARE IN INFLAMMATORY BOWEL DISEASE (IBD): RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY
PATIENT PERCEPTIONS ABOUT CAUSES OF FLARE IN INFLAMMATORY BOWEL DISEASE (IBD): RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY

Spyridon Siakavellas  et al.

Mistakes in acute jaundice and how to avoid them
Mistakes in acute jaundice and how to avoid them

Spyridon Siakavellas

PATIENT PERCEPTIONS ABOUT CAUSES OF FLARE IN INFLAMMATORY BOWEL DISEASE (IBD): RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY
PATIENT PERCEPTIONS ABOUT CAUSES OF FLARE IN INFLAMMATORY BOWEL DISEASE (IBD): RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY

BOTH SINGLE AND MULTIPLE SWITCHING BETWEEN INFLIXIMAB BIOSIMILARS CAN BE SAFE AND EFFECTIVE IN IBD: REAL WORLD OUTCOMES FROM THE EDINBURGH IBD UNIT
BOTH SINGLE AND MULTIPLE SWITCHING BETWEEN INFLIXIMAB BIOSIMILARS CAN BE SAFE AND EFFECTIVE IN IBD: REAL WORLD OUTCOMES FROM THE EDINBURGH IBD UNIT

Spyridon Siakavellas  et al.

FACTORS INDEPENDENTLY ASSOCIATED WITH FATIGUE IN IBD: RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY
FACTORS INDEPENDENTLY ASSOCIATED WITH FATIGUE IN IBD: RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY

Spyridon Siakavellas  et al.

PREDICCT COHORT BASELINE HABITUAL NUTRIENT INTAKE BY IBD PATIENTS
PREDICCT COHORT BASELINE HABITUAL NUTRIENT INTAKE BY IBD PATIENTS

Spyridon Siakavellas  et al.

LONG-TERM OUTCOMES FOLLOWING A SWITCH FROM ORIGINATOR ADALIMUMAB TO THE BIOSIMILAR SB5 (IMRALDI) IN IBD
LONG-TERM OUTCOMES FOLLOWING A SWITCH FROM ORIGINATOR ADALIMUMAB TO THE BIOSIMILAR SB5 (IMRALDI) IN IBD

Spyridon Siakavellas  et al.

HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY

Spyridon Siakavellas  et al.

Item 1 - 8 / 8
1